スポーツ医学市場 – 2029年までの世界予測

Report Overview

The global sports medicine market is expected to reach USD 9.45 Billion by 2029 from USD 6.79 Billion in 2024, growing at a CAGR of 6.8% during the forecast period.

世界のスポーツ医学市場は、2024年の67億9,000万米ドルから2029年までに94億5,000万米ドルに達すると予想されており、予測期間中に6.8%のCAGRで成長します。

The anticipated market growth for sports medicine market is supported by significant progress made in the field. The factors enhancing the demand comprise innovation and improvements in technologies, improved therapeutic efficiency and  uptake of major initiatives by government to increase the physical activity of citizens as well as to prevent sports related injuries. The limitations are the high cost of medical devices associated with sports medicine that may restrict many people in need from accessing such therapies.

“Body reconstruction products to register largest market share in 2022-2029.”

Body reconstruction products include implants, fracture & ligament repair products, arthroscopy devices, prosthetics and orthobiologics. Products for body reconstruction include prosthesis, arthroscopy equipment, implants, fracture and ligament repair supplies, and guthobiologics. Numerous contact sports, including basketball, rugby, and football, entail injuries that necessitate reconstruction, muscle or tendon fix, or replacement of the complete bone or cartilage tissue. To restore strength to large regions, implants may be used in a number of cases to replace missing bone. Furthermore, the injured site may also require the utilization of scaffold reconstruction material and OrthoBiologics. The frequency of fractures and ligament damage has gone up over time. Sports injuries involving the anterior cruciate ligament (ACL) are by far the most frequent. Meniscus, rotator cuff, and cartilage repairs are the three primary surgical techniques for ACL injuries. Repairing meniscals is the most typical process performed on the knee.

“Physiotherapy centers and clinics to register highest growth rate in the market during the forecast     period.”

Physiotherapy centers offer support and promote health of an individual’s lifestyle. Physiotherapists utlizes exercises and help to recover physical and mental well-being. There are various advantages associated with this segment. It can decrease pain, enhance joint movement, give strength, reduce inflammation, and betters cardio-respiratory role of the patient.

“Asia Pacific to register highest growth rate in the market during the forecast period.”

The highest CAGR was registered by the APAC region throughout the forecast period from 2024-2029. Asia Pacific comprise India, China, Japan, Australia, South Korea and RoAPAC. The Asia-Pacific region has shown significance growth for sports medicine market. Asia Pacific is projected to grow at a highest rate in sports medicine market for numerous reasons. Most importantly, sports medicine products are in high demand due to increase in participation in outdoor sports activities for professional or recreational purpose. Rise in fundings and increase in participation in different sports events such as Olympics are enhancing the growth of sports medicine market.

A number of drivers were responsible for the upswing, including:

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1–30%, Tier 2–42%, and Tier 3– 28%
• By Designation: C-level– 10%, Director-level–14%, and Others–76%
• By Region: North America–40%, Europe-30%, Asia Pacific–22%, Rest of the World -8%.

Prominent players in this market are Smith & Nephew (UK), DePuy Synthes (US), Stryker (US), Breg, Inc. (US), Conmed Corporation (US), Zimmer Biomet Holdings, INC. (US), Enovis (US), RTI Surgical (US), Performance Health International Limited (US), Bauerfeind AG (Germany), Arthrex, INC. (US), Karl Stprz GMBH & CP. KG (Germany), Mueller Sports Medicine, INC. (US), Ossur (Iceland), Ottobock SE & CO. KGAA (Germany), Biotek (India), Anika Therapeutics (US) among others.

Research Coverage

Products, applications, end users, and regions are the basis for the segmentation. The drivers, constraints, opportunities, and challenges that affect the market’s growth are all examined in this study. For stakeholders, the report outlines the prospects and challenges in the sports medicine sector. There are also more specifics on competitive landscapes of key players.  This study assesses micro markets in terms of their potential, growth trends, and contributions to the global sports medicine industry. With a focus on five key regions, the report projects a rise in market segment revenues.

Key Benefits of Buying the Report:

The report aims to assist new entrants and top players in the in sports medicine market in understanding the sustainability of investments. It also addresses the availability of comprehensive data for these purposes. These are the main benefits of purchasing the report. It will support thorough risk assessment procedures and investment decision-making. It provides accurate market segmentation, such as that based on end users and geographic factors, providing targeted segments with customized information. Additionally, it assesses the most important trends, difficulties, growth factors, and opportunities related to the same, enabling intelligent judgment and strategic decision-making.

The report provides the insights on the following pointers:

Analysis of the key drivers, restraints, opportunities, and challenges affecting the growth of the sports medicine market: Innovative technology and rise in cases of sports injury; high cost of devices and strict regulations; growing number of hospitals and increased therapies.

• Product Development/Innovation: Overview of pipeline technologies, research & development endeavors and introduction of novel product  & service for the sports medicine industry.
• Market Development: Comprehensive details regarding profitable markets: the study examines the sports medicine business in several geographical areas.
• Market Diversification: Thorough understanding of novel products, unexplored regions, current advancements, and investments in the sports medicine market.
• Competitive Assessment: Detailed assessment of market share, service offerings leading strategies of key players such as Smith & Nephew (UK), DePuy Synthes (US), Stryker (US), Zimmer Biomet Holdings, INC. (US) and Arthrex, INC. (US).

Table of Contents

1            INTRODUCTION            27

1.1         STUDY OBJECTIVES      27

1.2         MARKET DEFINITION   27

1.3         INCLUSIONS AND EXCLUSIONS 27

1.4         STUDY SCOPE  28

1.4.1      MARKETS COVERED     28

1.4.2      YEARS CONSIDERED     29

1.4.3      CURRENCY CONSIDERED          29

1.5         STAKEHOLDERS            29

1.6         SUMMARY OF CHANGES            30

1.7         IMPACT OF GEN AI        30

2            RESEARCH METHODOLOGY     31

2.1         RESEARCH DATA           31

2.2         RESEARCH DESIGN       31

2.2.1      SECONDARY RESEARCH             31

2.2.2      PRIMARY RESEARCH     33

2.2.2.1   Primary sources   33

2.2.2.2   Key industry insights          34

2.3         MARKET SIZE ESTIMATION       35

2.3.1      BOTTOM-UP APPROACH           36

2.3.1.1   Company revenue estimation approach         37

2.3.1.2   Customer-based market estimation approach 37

2.3.2      TOP-DOWN APPROACH             38

2.3.2.1   Primary interviews             38

2.3.2.2   CAGR projections             40

2.4         DATA TRIANGULATION             41

2.5         MARKET SHARE ASSESSMENT   41

2.6         RESEARCH ASSUMPTIONS         42

2.6.1      METHODOLOGY-RELATED ASSUMPTIONS       42

2.7         RESEARCH LIMITATIONS           42

2.8         RISK ASSESSMENT         42

3            EXECUTIVE SUMMARY 43

4            PREMIUM INSIGHTS      46

4.1         SPORTS MEDICINE MARKET OVERVIEW             46

4.2         SPORTS MEDICINE MARKET, BY REGION            47

4.3         ASIA PACIFIC SPORTS MEDICINE MARKET, BY COUNTRY AND END USER    48

4.4         SPORTS MEDICINE MARKET, BY KEY COUNTRY 49

5            MARKET OVERVIEW     50

5.1         INTRODUCTION            50

5.2         MARKET DYNAMICS     51

5.2.1      DRIVERS            51

5.2.1.1   Rising incidence of sports injuries    51

5.2.1.2   Increasing innovations in products and treatments       52

5.2.1.3   Growing adoption of 3D printing     53

5.2.2      RESTRAINTS     54

5.2.2.1   High cost of implants and other devices         54

5.2.2.2   Elevated risk of complications in sports injuries            54

5.2.3      OPPORTUNITIES           54

5.2.3.1   Emerging sports leagues and events 54

5.2.4      CHALLENGES   55

5.2.4.1   Risks associated with invasive injuries            55

5.3         INDUSTRY TRENDS       56

5.3.1      ROBOTIC SURGICAL SYSTEMS FOR ORTHOPEDICS       56

5.3.2      REGENERATIVE MEDICINE        56

5.3.3      BIOMECHANICS AND MOTION ANALYSIS          56

5.4         VALUE CHAIN ANALYSIS            57

5.4.1      RESEARCH & DEVELOPMENT   57

5.4.2      RAW MATERIAL PROCUREMENT AND MANUFACTURING          57

5.4.3      MARKETING & SALES, DISTRIBUTION, AND POST-SALES SERVICES              58

5.5         PORTER’S FIVE FORCES ANALYSIS         58

5.5.1      THREAT OF NEW ENTRANTS    59

5.5.2      THREAT OF SUBSTITUTES         59

5.5.3      BARGAINING POWER OF SUPPLIERS     59

5.5.4      BARGAINING POWER OF BUYERS           60

5.5.5      INTENSITY OF COMPETITIVE RIVALRY 60

5.6         PATENT ANALYSIS        60

5.7         KEY CONFERENCES AND EVENTS, 2024–2025     62

5.8         TRADE DATA ANALYSIS             64

5.8.1      IMPORT DATA 64

5.8.2      EXPORT DATA 64

5.9         PRICING ANALYSIS        65

5.9.1      AVERAGE SELLING PRICE TREND, BY REGION  65

5.9.2      AVERAGE SELLING PRICE TREND OF TOP 3 APPLICATIONS, BY KEY PLAYER 69

5.10       KEY STAKEHOLDERS AND BUYING CRITERIA    71

5.10.1    KEY STAKEHOLDERS IN BUYING PROCESS         71

5.10.2    BUYING CRITERIA         72

5.11       UNMET NEEDS AND KEY PAIN POINTS 73

5.12       ECOSYSTEM ANALYSIS 73

5.13       SUPPLY CHAIN ANALYSIS          74

5.13.1    PROMINENT COMPANIES          74

5.13.2    SMALL AND MEDIUM-SIZED ENTERPRISES        74

5.13.3    END USERS       74

5.14       TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES   75

5.15       TECHNOLOGY ANALYSIS           76

5.15.1    KEY TECHNOLOGIES    76

5.15.1.1 Wearable technology         76

5.15.1.2 Rehabilitation technology  76

5.15.1.3 Artificial intelligence and machine learning    76

5.15.1.4 3D printing and customization        77

5.15.2    COMPLEMENTARY TECHNOLOGIES     77

5.15.2.1 Biomechanics analysis        77

5.15.2.2 Regenerative medicine       77

5.15.2.3 Virtual reality and augmented reality             77

5.15.3    ADJACENT TECHNOLOGIES      77

5.15.3.1 Fitness and health apps      77

5.15.3.2 Telehealth platforms         77

5.15.3.3 Internet of Things              78

5.15.3.4 Data analytics and performance management software 78

5.15.3.5 Genomics and personalized medicine            78

5.16       CASE STUDY ANALYSIS 78

5.16.1    ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION AND CHONDROPLASTY OF KNEE     78

5.16.2    EFFECTIVENESS OF OSTEOPATHY IN TREATING SPORTS INJURIES              79

5.16.3    TOTAL HIP REPLACEMENT WITH AVASCULAR NECROSIS          79

5.17       REGULATORY LANDSCAPE       80

5.17.1    REGULATORY STANDARDS AND APPROVALS   80

5.17.1.1 North America     80

5.17.1.1.1            US         80

5.17.1.1.2            Canada  82

5.17.1.2 Europe  82

5.17.1.3 Asia Pacific          83

5.17.1.3.1            Japan     83

5.17.1.3.2            China     84

5.17.1.3.3            India      85

5.17.2    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS          86

5.18       INVESTMENT AND FUNDING SCENARIO            88

5.19       REIMBURSEMENT SCENARIO    89

5.20       IMPACT OF GEN AI ON SPORTS MEDICINE MARKET      91

6            SPORTS MEDICINE MARKET, BY APPLICATION 92

6.1         INTRODUCTION            93

6.2         KNEE INJURIES 93

6.2.1      GROWING CASES OF COLLATERAL LIGAMENT INJURIES AND TENDON TEARS TO FUEL MARKET           93

6.3         SHOULDER INJURIES    94

6.3.1      ADVANCEMENTS IN ARTHROSCOPIC SURGICAL TECHNOLOGY TO AID GROWTH   94

6.4         FOOT & ANKLE INJURIES           95

6.4.1      RISING PREFERENCE FOR FOOT & ANKLE RECONSTRUCTIONS TO AUGMENT GROWTH    95

6.5         HIP & GROIN INJURIES  96

6.5.1      SURGE IN OSTEOARTHRITIS CASES TO FACILITATE GROWTH  96

6.6         ELBOW & WRIST INJURIES          97

6.6.1      INCREASED HEALTHCARE EXPENDITURE TO EXPEDITE GROWTH              97

6.7         BACK & SPINE INJURIES 98

6.7.1      RISING EMPHASIS ON ENHANCING PATIENT OUTCOMES TO CONTRIBUTE TO MARKET GROWTH    98

6.8         OTHER INJURIES            99

7            SPORTS MEDICINE MARKET, BY END USER        101

7.1         INTRODUCTION            102

7.2         HOSPITALS       102

7.2.1      COMPLEX DIAGNOSTIC AND THERAPEUTIC PROCEDURES TO DRIVE MARKET            102

7.3         AMBULATORY SURGERY CENTERS        103

7.3.1      LIMITED HOSPITALIZATION AND BETTER AFFORDABILITY TO AID GROWTH          103

7.4         PHYSIOTHERAPY CENTERS & CLINICS  104

7.4.1      COST-EFFECTIVE AND NON-SURGICAL METHOD TO ACCELERATE GROWTH          104

8            SPORTS MEDICINE MARKET, BY PRODUCT        106

8.1         INTRODUCTION            107

8.2         REPAIR & RECONSTRUCTION PRODUCTS          107

8.2.1      FRACTURE & LIGAMENT REPAIR PRODUCTS    108

8.2.1.1   High incidence of sports and recreation-related trauma to encourage growth              108

8.2.2      ARTHROSCOPY DEVICES           110

8.2.2.1   Ability to minimize risk of infections and reduce recovery time to favor market growth   110

8.2.3      IMPLANTS         111

8.2.3.1   Growing popularity of minimally invasive surgical procedures to boost market              111

8.2.4      ORTHOBIOLOGICS       112

8.2.4.1   Ongoing research in regenerative medicine to promote growth  112

8.2.5      PROSTHETICS  113

8.2.5.1   Innovations in bionic technology, sensor technology, artificial intelligence, and micromechatronics to drive market  113

8.3         BODY SUPPORT & RECOVERY PRODUCTS         114

8.3.1      BRACES & SUPPORTS    115

8.3.1.1   Growing recommendations from physicians to augment growth 115

8.3.2      PHYSIOTHERAPY EQUIPMENT 116

8.3.2.1   Thermal therapy equipment            117

8.3.2.1.1 Increasing availability of reusable hot and cold packs to expedite growth  117

8.3.2.2   Electrostimulation equipment          118

8.3.2.2.1 Growing advancements in electronics to propel market 118

8.3.2.3   Other physiotherapy equipment      119

8.3.3      COMPRESSION CLOTHING        120

8.3.3.1   Surge in fitness centers and exercises in daily routines to speed up growth              120

8.4         ACCESSORIES   121

8.4.1      NEED FOR INJURY PREVENTION AND MANAGEMENT TO SUPPORT GROWTH          121

9            SPORTS MEDICINE MARKET, BY REGION            123

9.1         INTRODUCTION            124

9.2         NORTH AMERICA          124

9.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA   128

9.2.2      US         129

9.2.2.1   Favorable research activities and funding to favor market growth             129

9.2.3      CANADA            131

9.2.3.1   Growing prominence of regenerative medicine and stem cell therapy to fuel market   131

9.3         EUROPE             134

9.3.1      MACROECONOMIC OUTLOOK FOR EUROPE     137

9.3.2      GERMANY         138

9.3.2.1   Increased participation in sports and awareness of healthy lifestyles to sustain growth   138

9.3.3      UK         140

9.3.3.1   Availability of funding for sports medicine and athlete support to boost market              140

9.3.4      ITALY   142

9.3.4.1   Rise in sports-related injuries to augment growth         142

9.3.5      FRANCE             144

9.3.5.1   Initiatives related to Olympics to contribute to market growth   144

9.3.6      SPAIN   146

9.3.6.1   Rising popularity of football and high risk of injuries to fuel market         146

9.3.7      REST OF EUROPE           148

9.4         ASIA PACIFIC    151

9.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC          156

9.4.2      JAPAN  156

9.4.2.1   Rising number of total hip arthroplasty procedures and sports medicine fellowships to aid growth    156

9.4.3      CHINA  159

9.4.3.1   Growing focus on attaining higher fitness levels to drive market 159

9.4.4      AUSTRALIA       161

9.4.4.1   Surge in anterior cruciate ligament construction surgeries to encourage growth              161

9.4.5      INDIA   163

9.4.5.1   Booming sports infrastructure facilities to encourage growth     163

9.4.6      SOUTH KOREA 166

9.4.6.1   Favorable monetary support for sports-related activities to boost market  166

9.4.7      REST OF ASIA PACIFIC  168

9.5         LATIN AMERICA             170

9.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA     174

9.5.2      BRAZIL 175

9.5.2.1   Growing number of international sports events to propel market             175

9.5.3      MEXICO             177

9.5.3.1   Growth of private healthcare facilities to fuel market    177

9.5.4      REST OF LATIN AMERICA          179

9.6         MIDDLE EAST & AFRICA             181

9.6.1      MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA     185

9.6.2      GCC COUNTRIES           186

9.6.2.1   Strategic acquisitions and development of world-class stadiums to expedite growth              186

9.6.3      REST OF MIDDLE EAST & AFRICA           188

10          COMPETITIVE LANDSCAPE       191

10.1       OVERVIEW        191

10.2       KEY PLAYER STRATEGY/RIGHT TO WIN             191

10.2.1    OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN SPORTS MEDICINE MARKET      191

10.3       REVENUE ANALYSIS, 2021–2024 193

10.4       MARKET SHARE ANALYSIS, 2023             194

10.5       COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023   195

10.5.1    STARS  195

10.5.2    EMERGING LEADERS    195

10.5.3    PERVASIVE PLAYERS     195

10.5.4    PARTICIPANTS 196

10.5.5    COMPANY FOOTPRINT 197

10.5.5.1 Company footprint            197

10.5.5.2 Product footprint 197

10.5.5.3 Application footprint         198

10.5.5.4 End-user footprint             199

10.5.5.5 Region footprint  200

10.6       COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023          200

10.6.1    PROGRESSIVE COMPANIES       200

10.6.2    RESPONSIVE COMPANIES          201

10.6.3    DYNAMIC COMPANIES 201

10.6.4    STARTING BLOCKS       201

10.6.5    COMPETITIVE BENCHMARKING            202

10.7       COMPANY VALUATION AND FINANCIAL METRICS        204

10.8       BRAND/PRODUCT COMPARISON          205

10.9       COMPETITIVE SCENARIO          205

10.9.1    PRODUCT LAUNCHES AND APPROVALS            205

10.9.2    DEALS  206

10.9.3    EXPANSIONS    208

11          COMPANY PROFILES    209

11.1       KEY PLAYERS   209

11.1.1    ARTHREX, INC. 209

11.1.1.1 Business overview 209

11.1.1.2 Products offered  209

11.1.1.3 Recent developments         213

11.1.1.3.1            Product launches and approvals       213

11.1.1.3.2            Deals     214

11.1.1.4 MnM view           215

11.1.1.4.1            Right to win         215

11.1.1.4.2            Strategic choices  215

11.1.1.4.3            Weaknesses and competitive threats 215

11.1.2    SMITH+NEPHEW           216

11.1.2.1 Business overview 216

11.1.2.2 Products offered  217

11.1.2.3 Recent developments         219

11.1.2.3.1            Product launches and approvals       219

11.1.2.3.2            Deals     219

11.1.2.4 MnM view           220

11.1.2.4.1            Right to win         220

11.1.2.4.2            Strategic choices  220

11.1.2.4.3            Weaknesses and competitive threats 220

11.1.3    STRYKER           221

11.1.3.1 Business overview 221

11.1.3.2 Products offered  222

11.1.3.3 Recent developments         224

11.1.3.3.1            Product launches and approvals       224

11.1.3.3.2            Deals     224

11.1.3.3.3            Expansions          225

11.1.3.4 MnM view           225

11.1.3.4.1            Right to win         225

11.1.3.4.2            Strategic choices  225

11.1.3.4.3            Weaknesses and competitive threats 225

11.1.4    DEPUY SYNTHES           226

11.1.4.1 Business overview 226

11.1.4.2 Products offered  227

11.1.4.3 Recent developments         229

11.1.4.3.1            Product launches and approvals       229

11.1.4.3.2            Deals     229

11.1.4.4 MnM view           230

11.1.4.4.1            Right to win         230

11.1.4.4.2            Strategic choices  230

11.1.4.4.3            Weaknesses and competitive threats 230

11.1.5    ENOVIS 231

11.1.5.1 Business overview 231

11.1.5.2 Products offered  232

11.1.5.3 Recent developments         236

11.1.5.3.1            Product launches and approvals       236

11.1.5.3.2            Deals     236

11.1.5.3.3            Expansions          237

11.1.5.4 MnM view           237

11.1.5.4.1            Right to win         237

11.1.5.4.2            Strategic choices  237

11.1.5.4.3            Weaknesses and competitive threats 237

11.1.6    BREG, INC.         238

11.1.6.1 Business overview 238

11.1.6.2 Products offered  238

11.1.6.3 Recent developments         243

11.1.6.3.1            Product launches and approvals       243

11.1.6.3.2            Deals     243

11.1.7    CONMED CORPORATION          244

11.1.7.1 Business overview 244

11.1.7.2 Products offered  245

11.1.7.3 Recent developments         249

11.1.7.3.1            Deals     249

11.1.8    ZIMMER BIOMET           250

11.1.8.1 Business overview 250

11.1.8.2 Products offered  251

11.1.8.3 Recent developments         254

11.1.8.3.1            Product launches and approvals       254

11.1.8.3.2            Deals     255

11.1.8.3.3            Other developments          255

11.1.9    RTI SURGICAL  256

11.1.9.1 Business overview 256

11.1.9.2 Products offered  256

11.1.9.3 Recent developments         258

11.1.9.3.1            Deals     258

11.1.9.3.2            Other developments          258

11.1.10  PERFORMANCE HEALTH           259

11.1.10.1             Business overview 259

11.1.10.2             Products offered  259

11.1.10.3             Recent developments         261

11.1.10.3.1          Deals     261

11.1.11  BAUERFEIND    262

11.1.11.1             Business overview 262

11.1.11.2             Products offered  262

11.1.11.3             Recent developments         264

11.1.11.3.1          Product launches and approvals       264

11.1.12  KARL STORZ     265

11.1.12.1             Business overview 265

11.1.12.2             Products offered  265

11.1.12.3             Recent developments         267

11.1.12.3.1          Deals     267

11.1.13  MUELLER SPORTS MEDICINE, INC.        268

11.1.13.1             Business overview 268

11.1.13.2             Products offered  268

11.1.13.3             Recent developments         269

11.1.13.3.1          Deals     269

11.1.14  ÖSSUR  270

11.1.14.1             Business overview 270

11.1.14.2             Products offered  271

11.1.14.3             Recent developments         272

11.1.14.3.1          Product launches and approvals       272

11.1.14.3.2          Deals     272

11.1.14.3.3          Expansions          273

11.1.15  OTTOBOCK      274

11.1.15.1             Business overview 274

11.1.15.2             Products offered  274

11.1.15.3             Recent developments         277

11.1.15.3.1          Product launches and approvals       277

11.1.15.3.2          Deals     277

11.1.16  BIOTEK 278

11.1.16.1             Business overview 278

11.1.16.2             Products offered  278

11.1.17  ANIKA THERAPEUTICS, INC.      281

11.1.17.1             Business overview 281

11.1.17.2             Products offered  282

11.2       OTHER PLAYERS           284

11.2.1    BIOVENTUS      284

11.2.2    MIACH ORTHOPAEDICS            285

11.2.3    MONOGRAM ORTHOPEDICS    285

11.2.4    EPIBONE           286

11.2.5    ORTHALIGN     286

11.2.6    BLUE OCEAN SPINE GMBH        287

11.2.7    NELA BIODYNAMICS     287

11.2.8    PARAGON 28, INC.         288

11.2.9    ATEC SPINE, INC.           289

11.2.10  MEDTRONIC     290

12          APPENDIX         291

12.1       DISCUSSION GUIDE      291

12.2       KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL             295

12.3       CUSTOMIZATION OPTIONS      297

12.4       RELATED REPORTS       297

12.5       AUTHOR DETAILS         298

LIST OF TABLES

TABLE 1             SPORTS MEDICINE MARKET: INCLUSIONS AND EXCLUSIONS              27

TABLE 2             SPORTING EVENTS WORLDWIDE, 2023–2024      55

TABLE 3             SPORTS MEDICINE MARKET: IMPACT OF PORTER’S FIVE FORCES             58

TABLE 4             INNOVATIONS AND PATENT REGISTRATIONS, 2022–2024              61

TABLE 5            SPORTS MEDICINE MARKET: KEY CONFERENCES AND EVENTS, 2024–2025          62

TABLE 6             IMPORT DATA FOR HS CODE 902750, BY COUNTRY,

2019–2023 (USD THOUSAND)     64

TABLE 7             EXPORT DATA FOR HS CODE 902750, BY COUNTRY,

2019–2023 (USD THOUSAND)     64

TABLE 8             AVERAGE SELLING PRICE OF SPORTS MEDICINE EQUIPMENT, BY REGION,

2021–2023 (USD THOUSAND)     66

TABLE 9             AVERAGE SELLING PRICE OF TOP 3 APPLICATIONS, BY KEY PLAYER, 2023 (USD)      70

TABLE 10           INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%)           71

TABLE 11           KEY BUYING CRITERIA, BY END USER    72

TABLE 12           SPORTS MEDICINE MARKET: CURRENT UNMET NEEDS 73

TABLE 13           SPORTS MEDICINE MARKET: ROLE OF COMPANIES IN ECOSYSTEM     74

TABLE 14           REGULATORY STANDARDS/APPROVALS FOR SPORTS MEDICINE, BY COUNTRY           80

TABLE 15           US FOOD AND DRUG ADMINISTRATION: MEDICAL DEVICE CLASSIFICATION           81

TABLE 16           US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS              81

TABLE 17           CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS           82

TABLE 18           JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICALS AND MEDICAL DEVICES AGENCY 84

TABLE 19           CHINA: CLASSIFICATION OF MEDICAL DEVICES             84

TABLE 20           NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         86

TABLE 21           EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 86

TABLE 22           ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         87

TABLE 23           LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         87

TABLE 24           MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         88

TABLE 25           MAJOR CPT CODES FOR ORTHOPEDIC SURGERY IN US, 2023              89

TABLE 26           SPORTS MEDICINE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          93

TABLE 27           SPORTS MEDICINE MARKET FOR KNEE INJURIES, BY REGION,

2022–2029 (USD MILLION)          94

TABLE 28           SPORTS MEDICINE MARKET FOR SHOULDER INJURIES, BY REGION,

2022–2029 (USD MILLION)          95

TABLE 29           SPORTS MEDICINE MARKET FOR FOOT & ANKLE INJURIES, BY REGION,

2022–2029 (USD MILLION)          96

TABLE 30           SPORTS MEDICINE MARKET FOR HIP & GROIN INJURIES, BY REGION,

2022–2029 (USD MILLION)          97

TABLE 31           SPORTS MEDICINE MARKET FOR ELBOW & WRIST INJURIES, BY REGION,

2022–2029 (USD MILLION)          98

TABLE 32           SPORTS MEDICINE MARKET FOR BACK & SPINE INJURIES, BY REGION,

2022–2029 (USD MILLION)          99

TABLE 33          SPORTS MEDICINE MARKET FOR OTHER INJURIES, BY REGION,

2022–2029 (USD MILLION)          100

TABLE 34           SPORTS MEDICINE MARKET, BY END USER, 2022–2029 (USD MILLION)          102

TABLE 35           SPORTS MEDICINE MARKET FOR HOSPITALS, BY REGION,

2022–2029 (USD MILLION)          103

TABLE 36           SPORTS MEDICINE MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION,  2022–2029 (USD MILLION)         104

TABLE 37           SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY CENTERS & CLINICS,

BY REGION,  2022–2029 (USD MILLION)             105

TABLE 38           SPORTS MEDICINE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          107

TABLE 39           SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS,

BY TYPE, 2022–2029 (USD MILLION)       108

TABLE 40           SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS,

BY REGION,  2022–2029 (USD MILLION)             108

TABLE 41           SPORTS MEDICINE MARKET FOR FRACTURE & LIGAMENT REPAIR PRODUCTS,

BY REGION, 2022–2029 (USD MILLION)  109

TABLE 42           SPORTS MEDICINE MARKET FOR ARTHROSCOPY DEVICES, BY REGION,

2022–2029 (USD MILLION)          110

TABLE 43           SPORTS MEDICINE MARKET FOR IMPLANTS, BY REGION,

2022–2029 (USD MILLION)          111

TABLE 44           SPORTS MEDICINE MARKET FOR ORTHOBIOLOGICS, BY REGION,

2022–2029 (USD MILLION)          113

TABLE 45           SPORTS MEDICINE MARKET FOR PROSTHETICS, BY REGION,

2022–2029 (USD MILLION)          114

TABLE 46           SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS,

BY TYPE, 2022–2029 (USD MILLION)       114

TABLE 47           SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS,

BY REGION, 2022–2029 (USD MILLION)  115

TABLE 48           SPORTS MEDICINE MARKET FOR BRACES & SUPPORTS, BY REGION,

2022–2029 (USD MILLION)          116

TABLE 49           SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE,

2022–2029 (USD MILLION)          116

TABLE 50           SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY REGION,  2022–2029 (USD MILLION)   117

TABLE 51           SPORTS MEDICINE MARKET FOR THERMAL THERAPY EQUIPMENT, BY REGION,  2022–2029(USD MILLION)    118

TABLE 52           SPORTS MEDICINE MARKET FOR ELECTROSTIMULATION EQUIPMENT, BY REGION,  2022–2029 (USD MILLION)   119

TABLE 53           SPORTS MEDICINE MARKET FOR OTHER PHYSIOTHERAPY EQUIPMENT,

BY REGION, 2022–2029 (USD MILLION)  120

TABLE 54           SPORTS MEDICINE MARKET FOR COMPRESSION CLOTHING, BY REGION,

2022–2029 (USD MILLION)          121

TABLE 55           SPORTS MEDICINE MARKET FOR ACCESSORIES, BY REGION,

2022–2029 (USD MILLION)          122

TABLE 56           SPORTS MEDICINE MARKET, BY REGION, 2022–2029 (USD MILLION)          124

TABLE 57           NORTH AMERICA: SPORTS MEDICINE MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          125

TABLE 58           NORTH AMERICA: SPORTS MEDICINE MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          126

TABLE 59           NORTH AMERICA: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)     126

TABLE 60           NORTH AMERICA: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)              127

TABLE 61           NORTH AMERICA: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT,  BY TYPE, 2022–2029 (USD MILLION)    127

TABLE 62           NORTH AMERICA: SPORTS MEDICINE MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          128

TABLE 63           NORTH AMERICA: SPORTS MEDICINE MARKET, BY END USER,

2022–2029 (USD MILLION)          128

TABLE 64           NORTH AMERICA: MACROECONOMIC OUTLOOK          129

TABLE 65           US: SPORTS MEDICINE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          130

TABLE 66           US: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS,

BY TYPE, 2022–2029 (USD MILLION)       130

TABLE 67           US: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS,

BY TYPE,  2022–2029 (USD MILLION)    131

TABLE 68           US: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)     131

TABLE 69           CANADA: SPORTS MEDICINE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)     132

TABLE 70           CANADA: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS,  BY TYPE, 2022–2029 (USD MILLION)  133

TABLE 71           CANADA: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS,  BY TYPE, 2022–2029 (USD MILLION)   133

TABLE 72           CANADA: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE,  2022–2029 (USD MILLION)        134

TABLE 73           EUROPE: SPORTS MEDICINE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 134

TABLE 74           EUROPE: SPORTS MEDICINE MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 135

TABLE 75           EUROPE: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS,  BY TYPE, 2022–2029 (USD MILLION)  135

TABLE 76           EUROPE: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS,  BY TYPE, 2022–2029 (USD MILLION)   136

TABLE 77           EUROPE: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE,  2022–2029 (USD MILLION)        136

TABLE 78           EUROPE: SPORTS MEDICINE MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          137

TABLE 79           EUROPE: SPORTS MEDICINE MARKET, BY END USER, 2022–2029 (USD MILLION) 137

TABLE 80           EUROPE: MACROECONOMIC OUTLOOK            138

TABLE 81           GERMANY: SPORTS MEDICINE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)     139

TABLE 82           GERMANY: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS,  BY TYPE, 2022–2029 (USD MILLION)  139

TABLE 83           GERMANY: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS,  BY TYPE, 2022–2029 (USD MILLION) 140

TABLE 84           GERMANY: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT,

BY TYPE, 2022–2029 (USD MILLION)       140

TABLE 85           UK: SPORTS MEDICINE MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 141

TABLE 86           UK: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS,

BY TYPE, 2022–2029 (USD MILLION)       141

TABLE 87           UK: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS,

BY TYPE,  2022–2029 (USD MILLION)    142

TABLE 88           UK: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE,  2022–2029 (USD MILLION)        142

TABLE 89           ITALY: SPORTS MEDICINE MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 143

TABLE 90           ITALY: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS,  BY TYPE, 2022–2029 (USD MILLION)  143

TABLE 91           ITALY: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS,  BY TYPE, 2022–2029 (USD MILLION)   144

TABLE 92           ITALY: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE,  2022–2029 (USD MILLION)        144

TABLE 93           FRANCE: SPORTS MEDICINE MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 145

TABLE 94           FRANCE: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS,  BY TYPE, 2022–2029 (USD MILLION)  145

TABLE 95           FRANCE: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS,  BY TYPE, 2022–2029 (USD MILLION)   146

TABLE 96           FRANCE: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE,  2022–2029 (USD MILLION)        146

TABLE 97           SPAIN: SPORTS MEDICINE MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 147

TABLE 98           SPAIN: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS,  BY TYPE, 2022–2029 (USD MILLION)  147

TABLE 99           SPAIN: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS,  BY TYPE, 2022–2029 (USD MILLION)   148

TABLE 100         SPAIN: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE,  2022–2029 (USD MILLION)        148

TABLE 101         INDICATIVE LIST OF CONFERENCES IN REST OF EUROPE, 2022–2024          149

TABLE 102         REST OF EUROPE: SPORTS MEDICINE MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          149

TABLE 103         REST OF EUROPE: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)     150

TABLE 104         REST OF EUROPE: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)              150

TABLE 105         REST OF EUROPE: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT,  BY TYPE, 2022–2029 (USD MILLION)    151

TABLE 106         ASIA PACIFIC: SPORTS MEDICINE MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          153

TABLE 107         ASIA PACIFIC: SPORTS MEDICINE MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          153

TABLE 108         ASIA PACIFIC: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)     154

TABLE 109         ASIA PACIFIC: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)              154

TABLE 110         ASIA PACIFIC: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT,

BY TYPE,  2022–2029 (USD MILLION)    155

TABLE 111         ASIA PACIFIC: SPORTS MEDICINE MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          155

TABLE 112         ASIA PACIFIC: SPORTS MEDICINE MARKET, BY END USER,

2022–2029 (USD MILLION)          156

TABLE 113         ASIA PACIFIC: MACROECONOMIC OUTLOOK    156

TABLE 114         INDICATIVE LIST OF CONFERENCES IN JAPAN, 2024      157

TABLE 115         JAPAN: SPORTS MEDICINE MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 157

TABLE 116         JAPAN: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS,  BY TYPE, 2022–2029 (USD MILLION)  158

TABLE 117         JAPAN: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS,  BY TYPE, 2022–2029 (USD MILLION)   158

TABLE 118         JAPAN: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE,  2022–2029 (USD MILLION)        159

TABLE 119         CHINA: SPORTS MEDICINE MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 160

TABLE 120         CHINA: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS,  BY TYPE, 2022–2029 (USD MILLION)  160

TABLE 121         CHINA: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS,  BY TYPE, 2022–2029 (USD MILLION)   161

TABLE 122         CHINA: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE,  2022–2029 (USD MILLION)        161

TABLE 123         AUSTRALIA: SPORTS MEDICINE MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          162

TABLE 124         AUSTRALIA: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)     162

TABLE 125         AUSTRALIA: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)   163

TABLE 126         AUSTRALIA: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT,

BY TYPE, 2022–2029 (USD MILLION)       163

TABLE 127         INDIA: SPORTS MEDICINE MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 164

TABLE 128         INDIA: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS,  BY TYPE, 2022–2029 (USD MILLION)  165

TABLE 129         INDIA: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS,  BY TYPE, 2022–2029 (USD MILLION)   165

TABLE 130         INDIA: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE,  2022–2029 (USD MILLION)        166

TABLE 131         SOUTH KOREA: SPORTS MEDICINE MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          167

TABLE 132         SOUTH KOREA: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)     167

TABLE 133         SOUTH KOREA: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)              168

TABLE 134         SOUTH KOREA: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT,

BY TYPE, 2022–2029 (USD MILLION)       168

TABLE 135         REST OF ASIA PACIFIC: SPORTS MEDICINE MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          169

TABLE 136         REST OF ASIA PACIFIC: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)              169

TABLE 137         REST OF ASIA PACIFIC: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)              170

TABLE 138         REST OF ASIA PACIFIC: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT,  BY TYPE, 2022–2029 (USD MILLION)    170

TABLE 139         LATIN AMERICA: SPORTS MEDICINE MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          171

TABLE 140         LATIN AMERICA: SPORTS MEDICINE MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          171

TABLE 141         LATIN AMERICA: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)     172

TABLE 142         LATIN AMERICA: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)              172

TABLE 143         LATIN AMERICA: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE,  2022–2029 (USD MILLION)    173

TABLE 144         LATIN AMERICA: SPORTS MEDICINE MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          173

TABLE 145         LATIN AMERICA: SPORTS MEDICINE MARKET, BY END USER,

2022–2029 (USD MILLION)          174

TABLE 146         LATIN AMERICA: MACROECONOMIC OUTLOOK            174

TABLE 147         BRAZIL: SPORTS MEDICINE MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 175

TABLE 148         BRAZIL: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS,  BY TYPE, 2022–2029 (USD MILLION)  176

TABLE 149         BRAZIL: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS,  BY TYPE, 2022–2029 (USD MILLION)   176

TABLE 150         BRAZIL: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE,  2022–2029 (USD MILLION)        177

TABLE 151         INDICATIVE LIST OF CONFERENCES IN MEXICO, 2024–2025              177

TABLE 152         MEXICO: SPORTS MEDICINE MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 178

TABLE 153         MEXICO: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS,  BY TYPE, 2022–2029 (USD MILLION)  178

TABLE 154         MEXICO: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS,  BY TYPE, 2022–2029 (USD MILLION)   179

TABLE 155         MEXICO: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE,  2022–2029 (USD MILLION)        179

TABLE 156         REST OF LATIN AMERICA: SPORTS MEDICINE MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          180

TABLE 157         REST OF LATIN AMERICA: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)              180

TABLE 158         REST OF LATIN AMERICA: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)              181

TABLE 159         REST OF LATIN AMERICA: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION)       181

TABLE 160         MIDDLE EAST & AFRICA: SPORTS MEDICINE MARKET, BY REGION,

2022–2029 (USD MILLION)          182

TABLE 161         MIDDLE EAST & AFRICA: SPORTS MEDICINE MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          182

TABLE 162         MIDDLE EAST & AFRICA: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)              183

TABLE 163         MIDDLE EAST & AFRICA: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)              183

TABLE 164         MIDDLE EAST & AFRICA: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION)       184

TABLE 165         MIDDLE EAST & AFRICA: SPORTS MEDICINE MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          184

TABLE 166         MIDDLE EAST & AFRICA: SPORTS MEDICINE MARKET, BY END USER,

2022–2029 (USD MILLION)          185

TABLE 167         MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK              185

TABLE 168         GCC COUNTRIES: SPORTS MEDICINE MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          186

TABLE 169         GCC COUNTRIES: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)     187

TABLE 170         GCC COUNTRIES: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)              187

TABLE 171         GCC COUNTRIES: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT,  BY TYPE, 2022–2029 (USD MILLION)    188

TABLE 172         REST OF MIDDLE EAST & AFRICA: SPORTS MEDICINE MARKET, BY PRODUCT,  2022–2029 (USD MILLION)         188

TABLE 173         REST OF MIDDLE EAST & AFRICA: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)          189

TABLE 174         REST OF MIDDLE EAST & AFRICA: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)          189

TABLE 175         REST OF MIDDLE EAST & AFRICA: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION)              190

TABLE 176         OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SPORTS MEDICINE MARKET     191

TABLE 177         SPORTS MEDICINE MARKET: DEGREE OF COMPETITION              194

TABLE 178         SPORTS MEDICINE MARKET: PRODUCT FOOTPRINT    197

TABLE 179         SPORTS MEDICINE MARKET:  APPLICATION FOOTPRINT              198

TABLE 180         SPORTS MEDICINE MARKET:  END-USER FOOTPRINT 199

TABLE 181         SPORTS MEDICINE MARKET:  REGION FOOTPRINT      200

TABLE 182         SPORTS MEDICINE MARKET: DETAILED LIST OF STARTUPS/SMES           202

TABLE 183         SPORTS MEDICINE MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES     203

TABLE 184         SPORTS MEDICINE MARKET: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–AUGUST 2024     205

TABLE 185         SPORTS MEDICINE MARKET: DEALS, JANUARY 2021–AUGUST 2024      206

TABLE 186         SPORTS MEDICINE MARKET: EXPANSIONS, JANUARY 2021–AUGUST 2024    208

TABLE 187         ARTHREX, INC.: COMPANY OVERVIEW 209

TABLE 188         ARTHREX, INC.: PRODUCTS OFFERED  209

TABLE 189         ARTHREX, INC.: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–AUGUST 2024     213

TABLE 190         ARTHREX, INC.: DEALS, JANUARY 2021–AUGUST 2024    214

TABLE 191         SMITH+NEPHEW: COMPANY OVERVIEW            216

TABLE 192         SMITH+NEPHEW: PRODUCTS OFFERED             217

TABLE 193         SMITH+NEPHEW: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–AUGUST 2024     219

TABLE 194         SMITH+NEPHEW: DEALS, JANUARY 2021–AUGUST 2024 219

TABLE 195         STRYKER: PRODUCTS OFFERED             222

TABLE 196         STRYKER: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2024        224

TABLE 197         STRYKER: DEALS, JANUARY 2021–AUGUST 2024 224

TABLE 198         STRYKER: EXPANSIONS, JANUARY 2021–AUGUST 2024   225

TABLE 199         DEPUY SYNTHES: COMPANY OVERVIEW            226

TABLE 200         DEPUY SYNTHES: PRODUCTS OFFERED             227

TABLE 201         DEPUY SYNTHES: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–AUGUST 2024     229

TABLE 202         DEPUY SYNTHES: DEALS, JANUARY 2021–AUGUST 2024 229

TABLE 203         ENOVIS: COMPANY OVERVIEW 231

TABLE 204         ENOVIS: PRODUCTS OFFERED 232

TABLE 205         ENOVIS: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2024        236

TABLE 206         ENOVIS: DEALS, JANUARY 2021–AUGUST 2024   236

TABLE 207         ENOVIS: EXPANSIONS, JANUARY 2021–AUGUST 2024      237

TABLE 208         BREG, INC.: COMPANY OVERVIEW         238

TABLE 209         BREG, INC.: PRODUCTS OFFERED          238

TABLE 210         BREG, INC.: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–AUGUST 2024     243

TABLE 211         BREG, INC.: DEALS, JANUARY 2021–AUGUST 2024            243

TABLE 212         CONMED CORPORATION: COMPANY OVERVIEW           244

TABLE 213         CONMED CORPORATION: PRODUCTS OFFERED            245

TABLE 214         CONMED CORPORATION: DEALS, JANUARY 2021–AUGUST 2024      249

TABLE 215         ZIMMER BIOMET: COMPANY OVERVIEW            250

TABLE 216         ZIMMER BIOMET: PRODUCTS OFFERED            251

TABLE 217         ZIMMER BIOMET: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–AUGUST 2024     254

TABLE 218         ZIMMER BIOMET: DEALS, JANUARY 2021–AUGUST 2024 255

TABLE 219         ZIMMER BIOMET: OTHER DEVELOPMENTS, JANUARY 2021–AUGUST 2024    255

TABLE 220         RTI SURGICAL: COMPANY OVERVIEW   256

TABLE 221         RTI SURGICAL: PRODUCTS OFFERED   256

TABLE 222         RTI SURGICAL: DEALS, JANUARY 2021–AUGUST 2024     258

TABLE 223         RTI SURGICAL: OTHER DEVELOPMENTS, JANUARY 2021–AUGUST 2024    258

TABLE 224         PERFORMANCE HEALTH: COMPANY OVERVIEW            259

TABLE 225         PERFORMANCE HEALTH: PRODUCTS OFFERED             259

TABLE 226         PERFORMANCE HEALTH: DEALS, JANUARY 2021–AUGUST 2024              261

TABLE 227         BAUERFEIND: COMPANY OVERVIEW    262

TABLE 228         BAUERFEIND: PRODUCTS OFFERED     262

TABLE 229         BAUERFEIND: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–AUGUST 2024     264

TABLE 230         KARL STORZ: COMPANY OVERVIEW     265

TABLE 231         KARL STORZ: PRODUCTS OFFERED      265

TABLE 232         KARL STORZ: DEALS, JANUARY 2021–AUGUST 2024        267

TABLE 233         MUELLER SPORTS MEDICINE, INC.: COMPANY OVERVIEW              268

TABLE 234         MUELLER SPORTS MEDICINE, INC.: PRODUCTS OFFERED              268

TABLE 235         MUELLER SPORTS MEDICINE, INC.: DEALS, JANUARY 2021–AUGUST 2024    269

TABLE 236         ÖSSUR: COMPANY OVERVIEW  270

TABLE 237         ÖSSUR: PRODUCTS OFFERED   271

TABLE 238         ÖSSUR: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2024        272

TABLE 239         ÖSSUR: DEALS, JANUARY 2021–AUGUST 2024     272

TABLE 240         ÖSSUR: EXPANSIONS, JANUARY 2021–AUGUST 2024        273

TABLE 241         OTTOBOCK: COMPANY OVERVIEW       274

TABLE 242         OTTOBOCK: PRODUCTS OFFERED        274

TABLE 243         OTTOBOCK: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–AUGUST 2024     277

TABLE 244         OTTOBOCK: DEALS, JANUARY 2021–AUGUST 2024          277

TABLE 245         BIOTEK: COMPANY OVERVIEW 278

TABLE 246         BIOTEK: PRODUCTS OFFERED 278

TABLE 247         ANIKA THERAPEUTICS, INC.: COMPANY OVERVIEW      281

TABLE 248         ANIKA THERAPEUTICS, INC.: PRODUCTS OFFERED       282

TABLE 249         BIOVENTUS: COMPANY OVERVIEW       284

TABLE 250         MIACH ORTHOPAEDICS: COMPANY OVERVIEW             285

TABLE 251         MONOGRAM ORTHOPEDICS: COMPANY OVERVIEW     285

TABLE 252         EPIBONE: COMPANY OVERVIEW            286

TABLE 253         ORTHALIGN: COMPANY OVERVIEW      286

TABLE 254         BLUE OCEAN SPINE GMBH: COMPANY OVERVIEW         287

TABLE 255         NELA BIODYNAMICS: COMPANY OVERVIEW     287

TABLE 256         PARAGON 28, INC.: COMPANY OVERVIEW          288

TABLE 257         ATEC SPINE, INC.: COMPANY OVERVIEW           289

TABLE 258         MEDTRONIC: COMPANY OVERVIEW     290

LIST OF FIGURES

FIGURE 1           SPORTS MEDICINE MARKET SEGMENTATION  28

FIGURE 2           SPORTS MEDICINE MARKET: RESEARCH DESIGN           31

FIGURE 3           KEY DATA FROM SECONDARY SOURCES            33

FIGURE 4           BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 34

FIGURE 5           BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION    35

FIGURE 6           RESEARCH METHODOLOGY: HYPOTHESIS BUILDING  36

FIGURE 7           SPORTS MEDICINE MARKET SIZE ESTIMATION: COMPANY REVENUE ESTIMATION APPROACH      37

FIGURE 8           SPORTS MEDICINE MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH       38

FIGURE 9           SPORTS MEDICINE MARKET SIZE ESTIMATION: TOP-DOWN APPROACH       38

FIGURE 10         CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS   40

FIGURE 11         DATA TRIANGULATION             41

FIGURE 12         SPORTS MEDICINE MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)          43

FIGURE 13         SPORTS MEDICINE MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)          44

FIGURE 14         SPORTS MEDICINE MARKET, BY REGION, 2024–2029      44

FIGURE 15         RISE IN NUMBER OF SPORTS-RELATED INJURIES AND DEVELOPMENT OF SPORTS TRAINING CENTERS TO DRIVE MARKET    46

FIGURE 16         NORTH AMERICA TO LEAD MARKET IN 2024     47

FIGURE 17         JAPAN AND HOSPITALS SEGMENT DOMINATED ASIA PACIFIC MARKET IN 2023             48

FIGURE 18         CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD              49

FIGURE 19         SPORTS MEDICINE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    51

FIGURE 20         SPORTS MEDICINE MARKET: VALUE CHAIN ANALYSIS  58

FIGURE 21         SPORTS MEDICINE MARKET: PORTER’S FIVE FORCES ANALYSIS          59

FIGURE 22         SPORTS MEDICINE MARKET: PATENT ANALYSIS, 2013–2023              60

FIGURE 23         AVERAGE SELLING PRICE TREND OF SPORTS MEDICINE EQUIPMENT,  BY REGION, 2021–2023 (USD THOUSAND) (1/2)  68

FIGURE 24         AVERAGE SELLING PRICE TREND OF SPORTS MEDICINE EQUIPMENT,  BY REGION, 2021–2023 (USD THOUSAND) (2/2)  69

FIGURE 25         AVERAGE SELLING PRICE OF TOP 3 APPLICATIONS, BY KEY PLAYER, 2023 (USD)      70

FIGURE 26         INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER    71

FIGURE 27         KEY BUYING CRITERIA, BY END USER    72

FIGURE 28         SPORTS MEDICINE MARKET: ECOSYSTEM ANALYSIS     73

FIGURE 29         SPORTS MEDICINE MARKET: SUPPLY CHAIN ANALYSIS 75

FIGURE 30         REVENUE SHIFT AND NEW REVENUE POCKETS IN SPORTS MEDICINE MARKET      75

FIGURE 31         INVESTMENT AND FUNDING SCENARIO, 2018–2022       88

FIGURE 32         NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2018–2022              89

FIGURE 33         DEAL VALUE OF INVESTMENT, BY KEY PLAYER, 2018–2022 (USD MILLION) 89

FIGURE 34         NORTH AMERICA: SPORTS MEDICINE MARKET SNAPSHOT              125

FIGURE 35         ASIA PACIFIC: SPORTS MEDICINE MARKET SNAPSHOT 152

FIGURE 36         REVENUE ANALYSIS OF TOP FIVE PLAYERS IN SPORTS MEDICINE MARKET,

2021–2024 (USD MILLION)          193

FIGURE 37        SPORTS MEDICINE MARKET SHARE ANALYSIS OF KEY PLAYERS, 2023      194

FIGURE 38         SPORTS MEDICINE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023     196

FIGURE 39         SPORTS MEDICINE MARKET: COMPANY FOOTPRINT    197

FIGURE 40         SPORTS MEDICINE MARKET: COMPANY EVALUATION MATRIX

(STARTUPS/SMES), 2023             201

FIGURE 41         EV/EBITDA OF KEY VENDORS   204

FIGURE 42         YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF

KEY VENDORS  204

FIGURE 43         SPORTS MEDICINE MARKET: BRAND/PRODUCT COMPARISON              205

FIGURE 44         SMITH+NEPHEW: COMPANY SNAPSHOT (2023) 217

FIGURE 45         STRYKER: COMPANY SNAPSHOT (2023) 222

FIGURE 46         DEPUY SYNTHES: COMPANY SNAPSHOT (2023) 227

FIGURE 47         ENOVIS: COMPANY SNAPSHOT (2023)   232

FIGURE 48         CONMED CORPORATION: COMPANY SNAPSHOT (2023)              245

FIGURE 49         ZIMMER BIOMET: COMPANY SNAPSHOT (2023) 251

FIGURE 50         ÖSSUR: COMPANY SNAPSHOT (2023)    271

FIGURE 51         ANIKA THERAPEUTICS, INC.: COMPANY SNAPSHOT (2023)              282

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧